Sunday, December 14, 2025 | 02:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Samrat Pharmachem standalone net profit declines 4.00% in the September 2020 quarter

Image

Capital Market

Sales rise 13.57% to Rs 41.50 crore

Net profit of Samrat Pharmachem declined 4.00% to Rs 1.44 crore in the quarter ended September 2020 as against Rs 1.50 crore during the previous quarter ended September 2019. Sales rose 13.57% to Rs 41.50 crore in the quarter ended September 2020 as against Rs 36.54 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales41.5036.54 14 OPM %6.435.67 -PBDT2.412.26 7 PBT2.292.15 7 NP1.441.50 -4

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 14 2020 | 2:17 PM IST

Explore News